MJStocks Friday Update- 8/31/2018!
GT Biopharma (GTBP) Continues To Surge
As we head into a long weekend, GT Biopharma continues to surge. This week, GT Biopharma (GTBP) has been trending after it made a major announcement that the company has initiated a combination trial of its OXS-1550 with a multi-billion dollar oncology drug, owned by a Major Pharmaceutical Company. Since making this announcement, GT’s market has been on fire. Have you been paying attention?
Click Here To Read More
InCaseYouMissedIt:Beleave Inc. (BLEVF) Secures Prime Location for its First Saskatchewan Retail Store
Beleave Inc. (BE.CN) (BLEVF) (“Beleave” or the “Company”) is excited to announce that it has secured a prime location for its first Saskatchewan retail store in the city of Lloydminster.
Click Here For More
Alcohol Distributors Move Into The Marijuana Sector
The marijuana industry has been extremely lucrative over the course of the past several years, but new updates to legislation and the changing public perception of cannabis have all meant that many individuals are deciding to get into the market that never would have before. This seems to be the case as many of the largest alcohol distributors and producers in the world have decided to get involved in the marijuana space, by giving massive investments to companies in the sector.
Click Here For Full Release
Disclaimer: Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and GT Biopharma, Midam has been paid $200,000 from the company and ZERO shares of GT Biopharma Inc. for a duration beginning July 16, 2018 and ending August 16, 2018. Midam Ventures has been paid an additional $200k by GT Biopharma and has extended its marketing period through Sept 16, 2018. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and Beleave Inc., Midam has been paid $200,000 from the company and ZERO shares of Beleave Inc. for a duration of 6 weeks beginning June 18, 2018 and ending July 31, 2018 NOW EXTENDED TO 8/31/2018. We may buy or sell additional shares of (BLEVF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
